Artificial Intelligence Applications in Breast Imaging: Current Status and Future Directions.
Clayton R TaylorNatasha MongaCandise JohnsonJeffrey R HawleyMitva PatelPublished in: Diagnostics (Basel, Switzerland) (2023)
Attempts to use computers to aid in the detection of breast malignancies date back more than 20 years. Despite significant interest and investment, this has historically led to minimal or no significant improvement in performance and outcomes with traditional computer-aided detection. However, recent advances in artificial intelligence and machine learning are now starting to deliver on the promise of improved performance. There are at present more than 20 FDA-approved AI applications for breast imaging, but adoption and utilization are widely variable and low overall. Breast imaging is unique and has aspects that create both opportunities and challenges for AI development and implementation. Breast cancer screening programs worldwide rely on screening mammography to reduce the morbidity and mortality of breast cancer, and many of the most exciting research projects and available AI applications focus on cancer detection for mammography. There are, however, multiple additional potential applications for AI in breast imaging, including decision support, risk assessment, breast density quantitation, workflow and triage, quality evaluation, response to neoadjuvant chemotherapy assessment, and image enhancement. In this review the current status, availability, and future directions of investigation of these applications are discussed, as well as the opportunities and barriers to more widespread utilization.
Keyphrases
- artificial intelligence
- machine learning
- big data
- deep learning
- high resolution
- neoadjuvant chemotherapy
- risk assessment
- current status
- healthcare
- emergency department
- quality improvement
- primary care
- heavy metals
- public health
- real time pcr
- lymph node
- computed tomography
- squamous cell carcinoma
- magnetic resonance
- metabolic syndrome
- young adults
- early stage
- label free
- adipose tissue
- mass spectrometry
- photodynamic therapy
- sentinel lymph node
- liquid chromatography tandem mass spectrometry
- childhood cancer